NLRP3 and hypertensive disorder: Recently, a non-targeted metabolomics approach revealed nutritional intervention with β-OHB reversed the high salt-induced adverse effects including renal NLRP3-mediated inflammation, fibrosis, and hypertension (Chakraborty et al., 2018).